2004 Fiscal Year Final Research Report Summary
Prevalence of asymptomatic chlamydial infecton among students and development of preventive screening methods.
Project/Area Number |
15390205
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Public health/Health science
|
Research Institution | University of Miyazaki (2004) 宮崎医科大学 (2003) |
Principal Investigator |
KATOH Takahiko Miyazaki Medical College, University of Miyazaki, Department of Public Health, professor, 医学部, 教授 (70169506)
|
Co-Investigator(Kenkyū-buntansha) |
IMAI Hirohisa Asahikawa Medical College, Department of Health Science, associate professor, 医学部, 助教授 (20316631)
HAMASUNA Ryoichi Miyazaki Medical College, University of Miyazaki, Department of Urology, assistant professor, 医学部, 講師 (30189609)
NAKAO Hiroyuki Miyazaki Medical College, University of Miyazaki, Department of Public Health, assistant, 医学部, 助手 (40336293)
SHINOHARA Hisae University of Miyazaki, Faculty of Education and Culture, associate professor, 教育文化学部, 助教授 (40178885)
|
Project Period (FY) |
2003 – 2004
|
Keywords | chlamydia trachomatis / mass screening / patient selection / PCR / prevalence / rsk factor / students / パートナー数 |
Research Abstract |
Asymptomatic chlamydial infection among general student populations has not yet been detected epidemiologically. Previous surveys have analyzed data from potentially biased samples, not general student populations. To describe prevalence, risk factors and screening methods for asymptomatic chlamydial infection among students, population-based cross-sectional surveys were implemented. Participants comprised 10,111 asymptomatic student volunteers【greater than or equal】18-years-old. Prevalence was 9.6% for females and 6.7% for males. The authors describe reliable epidemiological information and screening methods to facilitate improved coverage and reduce bias among general student populations. Selective criteria including risky sexual behaviors will allow efficient screening for infected individuals.
|